{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:48:23Z","timestamp":1776984503825,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00345-018-2409-1","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T11:04:44Z","timestamp":1531998284000},"page":"539-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7805-6651","authenticated-orcid":false,"given":"Stavros","family":"Gravas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Samarinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina","family":"Zacharouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Karatzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Tzortzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Koukoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Melekos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"issue":"6","key":"2409_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","volume":"54","author":"JC Nickel","year":"2008","unstructured":"Nickel JC, Roehrborn CG, O\u2019Leary MP, Bostwick DG, Somerville MC, Rittmaster RS (2008) The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 54(6):1379\u20131384","journal-title":"Eur Urol"},{"key":"2409_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","volume":"60","author":"C Nunzio De","year":"2011","unstructured":"De Nunzio C, Kramer G, Marberger M et al (2011) The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 60:106\u2013117","journal-title":"Eur Urol"},{"key":"2409_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0302-2838(02)00548-1","volume":"43","author":"F Silverio Di","year":"2003","unstructured":"Di Silverio F, Gentile V, De Matteis A et al (2003) Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol 43:164\u2013175","journal-title":"Eur Urol"},{"key":"2409_CR4","doi-asserted-by":"publisher","unstructured":"Samarinas M, Gacci M, de la Taille A,\u00a0Gravas S (2018) Prostatic inflammation: a potential treatment target for male LUTS due to benign prostatic obstruction. Prostate Cancer Prostatic Dis. \n                    https:\/\/doi.org\/10.1038\/s41391-018-0039-8","DOI":"10.1038\/s41391-018-0039-8"},{"key":"2409_CR5","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1097\/01.ju.0000140503.11467.8e","volume":"172","author":"AC Buck","year":"2004","unstructured":"Buck AC (2004) Is there a scientific basis for the therapeutic effects of Serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J Urol 172:1792\u20131799","journal-title":"J Urol"},{"key":"2409_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.eursup.2013.08.003","volume":"12","author":"A Taille De la","year":"2013","unstructured":"De la Taille A (2013) Therapeutic approach: the importance of controlling prostatic inflammation. Eur Urol Suppl 12:116\u2013122","journal-title":"Eur Urol Suppl"},{"key":"2409_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0302-2838(03)00368-3","volume":"44","author":"R Vela Navarrete","year":"2003","unstructured":"Vela Navarrete R, Garcia Cardoso JV, Barat A, Manzarbeitia F, L\u00f3pez Farr\u00e9 A (2003) BPH and inflammation: pharmacological effects of permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay. Eur Urol 44:549\u2013555","journal-title":"Eur Urol"},{"issue":"16","key":"2409_CR8","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/pros.23059","volume":"75","author":"A Latil","year":"2015","unstructured":"Latil A, P\u00e9trissans MT, Rouquet J et al (2015) Effects of hexanic extract of Serenoa repens (Permixon\u00ae 160\u00a0mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Prostate 75(16):1857\u20131867","journal-title":"Prostate"},{"issue":"4","key":"2409_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J (1997) Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 157(4):1301\u20131303","journal-title":"J Urol"},{"issue":"16","key":"2409_CR10","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/pros.21027","volume":"69","author":"G Robert","year":"2009","unstructured":"Robert G, Descazeaud A, Nicola\u00efew N, Terry S, Sirab N, Vacherot F, Maill\u00e9 P, Allory Y, de la Taille A (2009) Inflammation in benign prostatic hyperplasia: a 282 patients\u2019 immunohistochemical analysis. Prostate 69(16):1774\u20131780","journal-title":"Prostate"},{"issue":"5","key":"2409_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.euf.2016.04.002","volume":"2","author":"G Novara","year":"2016","unstructured":"Novara G, Giannarini G, Alcaraz A et al (2016) Efficacy and safety of hexanic lipidosterolic extract of Serenoa repens (Permixon) in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials. Eur Urol Focus 2(5):553\u2013561","journal-title":"Eur Urol Focus"},{"key":"2409_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14362","author":"R Vela-Navarrete","year":"2018","unstructured":"Vela-Navarrete R, Alcaraz A, Rodr\u00edguez-Antol\u00edn A et al (2018) Efficacy and safety of a\u00a0hexanic\u00a0extract of\u00a0Serenoa repens\u00a0(Permixon\u00ae) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS\/BPH): systematic review and meta-analysis of randomized controlled trials and observational studies. BJU Int. \n                    https:\/\/doi.org\/10.1111\/bju.14362\n                    \n                  \n                           (in press)","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2409-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T17:30:28Z","timestamp":1566927028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,19]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2409"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2409-1","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,19]]},"assertion":[{"value":"1 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Stavros Gravas has received speaker honoraria from Astellas, Pierre Fabre Medicament and consultancy honoraria from Astellas and GSK. Michael Samarinas, Konstantina Zacharouli, Anastasios Karatzas, Georgios Koukoulis, Vasileios Tzortzis, Michael Melekos declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}